ArticleJournal of clinical medicine2023

CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation.

Barbara Wlodarczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.